Senores Pharmaceuticals shareholding pattern

SENORES

HealthcareMid

696.75

21.50 (3.18%)
Last updated on 18 Aug, 2025 | 15:50 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Senores Pharmaceuticals Shareholding Pattern

  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

45.78%

Mutual Fund

3%

Insurance

4.05%

Foreign Institutional Investors

3.66%

Domestic Institutional Investors

2.47%

Retail

41.04%

Others

0%

Total Promoters
MAR '25
45.77%
JUN '25
45.78%

Senores Pharmaceuticals FAQs

As of 08-2025, the promoter shareholding in Senores Pharmaceuticals stands at 45.78% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Senores Pharmaceuticals is 3.66% and 2.47% respectively.

The retail shareholding of the Senores Pharmaceuticals is 41.04%.

Changes in shareholding patterns of Senores Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Senores Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.